[HTML][HTML] Nitric oxide and arterial disease

JE Barbato, E Tzeng - Journal of vascular surgery, 2004 - Elsevier
JE Barbato, E Tzeng
Journal of vascular surgery, 2004Elsevier
Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of
vascular disease. NO has a number of intracellular effects that lead to vasorelaxation,
endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role
in vascular disease has been intensively investigated and further elucidated over the past
two decades. It is important in the pathogenesis of many cardiovascular diseases, including
atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been …
Nitric oxide (NO) is a molecule that has gained recognition as a crucial modulator of vascular disease. NO has a number of intracellular effects that lead to vasorelaxation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet adhesion. Its role in vascular disease has been intensively investigated and further elucidated over the past two decades. It is important in the pathogenesis of many cardiovascular diseases, including atherosclerosis, intimal hyperplasia, and aneurysmal disease. In addition, NO has been used as a therapeutic tool to treat diseases that range from recurrent stenosis to inhibiting thrombotic events. Many commonly used medications have their therapeutic actions through the production of NO. This review highlights the vascular biologic characteristics of NO, its role in the pathogenesis of cardiovascular disease processes, and its potential therapeutic applications.
Elsevier